AlertWatch:OB vs PeriGen (2026)
The obstetric early warning shortlist, and with only two credible occupants this is a real decision rather than a manufactured one. PeriGen has the deeper regulatory history, with multiple cleared components for automated fetal heart rate interpretation and labor progress, and the only independent validation in this category performed by experts at a federal research institute rather than by the vendor or a customer. AlertWatch:OB started from a different premise: alarm fatigue was the founding design problem, and the filtering layer that follows from that is the thing to test, because a labor and delivery unit is already saturated with alarms and a system that adds to them will be ignored. Neither publishes any subgroup performance analysis, which in United States obstetrics, where maternal outcomes differ sharply by race, is the most important omission on either record.
- Alarm fatigue was the founding design problem rather than a later fix, with a proprietary filtering layer over the alert stream, which is the correct starting point in a unit where continuous monitoring already produces more alarms than anyone can act on.
- A repeated clearance history across three products covering the operating room, acute care and obstetrics, so the regulatory approach is established rather than product specific.
- It ingests hundreds of data elements across physiological monitors, the record system and laboratory feeds rather than reading one source, which is what a maternal early warning score needs.
- Its algorithms were validated by experts at a federal research institute rather than by the company or its customers, which is the only independent validation of that kind in this category.
- The deepest and longest regulatory history here, with multiple cleared components across years covering automated fetal heart rate interpretation and labor progress.
- It draws continuously from the hospital's existing fetal monitoring infrastructure rather than requiring it to be replaced, and its named deployments span an unusually wide range of institution types.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AlertWatch:OB and PeriGen are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AlertWatch:OB | PeriGen |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Founded | 2012 | Not recorded |
| Headquarters | Ann Arbor, Michigan | Cary, North Carolina |
| Website | alertwatch.com | perigen.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index records no top capability grade for AlertWatch:OB on any axis it scores. Set against PeriGen, AlertWatch:OB does not grade higher on any scored axis, though the two are level on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards PeriGen its top capability grade on FDA and Regulatory Status. Set against AlertWatch:OB, PeriGen grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose AlertWatch:OB or PeriGen?
The AI Health Index grades PeriGen higher than AlertWatch:OB on every axis that separates them, several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. AlertWatch:OB does not grade higher on any scored axis.
Where do AlertWatch:OB and PeriGen differ most?
The widest separation the AI Health Index records between AlertWatch:OB and PeriGen is on AI Centrality, where AlertWatch:OB grades C and PeriGen grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do AlertWatch:OB and PeriGen grade the same?
The AI Health Index grades AlertWatch:OB and PeriGen the same on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have AlertWatch:OB and PeriGen not disclosed?
At the last review, at least one of AlertWatch:OB and PeriGen published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
Neither vendor publishes subgroup performance, calibration or fairness analysis, and obstetrics is the clinical domain where that gap costs most: maternal mortality and severe morbidity in the United States differ sharply by race, and an early warning system that performs unevenly across those groups would widen rather than narrow the gap it is sold to close.
Neither publishes a privacy policy, retention period, training use disclosure, security attestation, trust centre or business associate terms, and neither publishes pricing. AlertWatch's named deployments are dated enough that a buyer should ask for current reference sites rather than relying on the published list.